A detailed history of Lfa Lugano Financial Advisors Sa transactions in Eli Lilly & CO stock. As of the latest transaction made, Lfa Lugano Financial Advisors Sa holds 167 shares of LLY stock, worth $131,163. This represents 0.1% of its overall portfolio holdings.

Number of Shares
167
Previous 153 9.15%
Holding current value
$131,163
Previous $138,000 6.52%
% of portfolio
0.1%
Previous 0.11%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$772.14 - $960.02 $10,809 - $13,440
14 Added 9.15%
167 $147,000
Q2 2024

Jul 30, 2024

BUY
$724.87 - $909.04 $10,148 - $12,726
14 Added 10.07%
153 $138,000
Q4 2023

Jan 22, 2024

BUY
$525.19 - $619.13 $14,705 - $17,335
28 Added 25.23%
139 $81,000
Q3 2023

Oct 23, 2023

BUY
$434.7 - $599.3 $48,251 - $66,522
111 New
111 $59,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $746B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Lfa Lugano Financial Advisors Sa Portfolio

Follow Lfa Lugano Financial Advisors Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lfa Lugano Financial Advisors Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lfa Lugano Financial Advisors Sa with notifications on news.